Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-18-000855
Filing Date
2018-01-04
Accepted
2018-01-04 16:42:24
Documents
1
Period of Report
2018-01-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 1489
  Complete submission text file 0001140361-18-000855.txt   2932
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Issuer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 65 WEST WATKINS MILL ROAD GAITHERSBURG MD 20878
Business Address
Swirsky Douglas J (Reporting) CIK: 0001375884 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34079 | Film No.: 18510646